Puma Biotechnology Inc Logo Image

Puma Biotechnology Inc

Puma Biotechnology Inc Banner Image

Puma Biotechnology Inc has reached its limit for report views.

Please check back to see if Puma Biotechnology Inc has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

About Puma Biotechnology Inc

51-200 Employees
Based in Los Angeles, California

Puma Biotechnology, Inc., a development stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of products for the treatment of various forms of cancer. Its drug candidates include PB272 (neratinib (oral)) for the treatment of advanced breast cancer patients, non-small cell lung cancer patients, and patients with HER2 mutation-positive solid tumors; and PB272 (neratinib (intravenous)) for the treatment of advanced cancer patients.

Ticker:
PBYI
Exchange:
NYSE (See More NYSE Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol